Greater Paris University Hospitals - AP-HP
Michel Roux is an experienced professional in clinical operations and research, currently serving as VP of Clinical Operations and Clinical Development at GenSight Biologics since February 2020, where responsibilities include supporting clinical development and EMA submissions for a gene therapy targeting blindness. Concurrently, Michel Roux works part-time as a Hospital MD at AP-HP in Oncology-immunology and Internal medicine. Previous roles include leadership positions in several prominent biotech and pharmaceutical companies, overseeing global clinical development strategies and regulatory processes at DBV Technologies, Stallergenes, Sanofi, SERVIER, BIOPROJET Pharma, Boston Scientific, Medpass, and FDM Pharma. Michel Roux holds a Doctor of Medicine degree in Pharmacology and has furthered education with advanced training in clinical trial methodology and immunology.
This person is not in any teams
Greater Paris University Hospitals - AP-HP
AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there.